Articles with "peritoneal carcinomatosis" as a keyword



Photo by eriic from unsplash

Engineering Alendronate‐Composed Iron Nanochelator for Efficient Peritoneal Carcinomatosis Treatment

Sign Up to like & get
recommendations!
Published in 2022 at "Advanced Science"

DOI: 10.1002/advs.202203031

Abstract: Iron is an essential element for various cellular metabolism. Cancer cells also have high requirement of iron in their proliferation, invasion, and metastasis processes. Alendronate (ALN), a kind of FDA‐approved bisphosphonates with metal‐chelating capability, is… read more here.

Keywords: iron nanochelator; peritoneal carcinomatosis; iron; treatment ... See more keywords
Photo from wikipedia

Postoperative complications affect long‐term outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis

Sign Up to like & get
recommendations!
Published in 2017 at "Journal of Surgical Oncology"

DOI: 10.1002/jso.24632

Abstract: Morbidity after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS + HIPEC) for colorectal peritoneal carcinomatosis (PC) may negatively affect survival. The objective was to determine the impact of postoperative complications (CX) on survival in patients undergoing CRS + HIPEC… read more here.

Keywords: hyperthermic intraperitoneal; surgery hyperthermic; colorectal peritoneal; intraperitoneal chemotherapy ... See more keywords
Photo from wikipedia

Inferior epigastric artery lymph nodes: A pathway for systemic dissemination from peritoneal carcinomatosis?

Sign Up to like & get
recommendations!
Published in 2020 at "Journal of Surgical Oncology"

DOI: 10.1002/jso.26269

Abstract: We report, for the first time in the literature, a metastatic lymphatic pathway along the inferior epigastric vessels, through the inferior epigastric lymph nodes (IELNs), in patients with peritoneal carcinomatosis (PC). Interestingly, these lymph nodes… read more here.

Keywords: systemic dissemination; peritoneal carcinomatosis; lymph nodes; inferior epigastric ... See more keywords
Photo from wikipedia

Starting a peritoneal carcinomatosis treatment program in a developing country: A prospective analysis.

Sign Up to like & get
recommendations!
Published in 2021 at "Journal of surgical oncology"

DOI: 10.1002/jso.26626

Abstract: BACKGROUND Cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) has become a valuable treatment strategy for selected patients with peritoneal carcinomatosis (PC). In Chile, it is an emerging technique. The aim of this study is… read more here.

Keywords: starting peritoneal; treatment program; treatment; peritoneal carcinomatosis ... See more keywords
Photo by sammiechaffin from unsplash

Reply to Comment on “Risk factors for metachronous peritoneal carcinomatosis after radical resection for patients with nonmetastatic pT3‐4 colon cancer”

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of Surgical Oncology"

DOI: 10.1002/jso.27037

Abstract: comments concerning our manuscript entitled “ Risk factors for metachronous peritoneal carcinomatosis after radical resection for patients with nonmetastatic pT3 ‐ 4 colon cancer. ” 1 These comments are valuable, are of great help to… read more here.

Keywords: peritoneal carcinomatosis; risk factors; factors metachronous; metachronous peritoneal ... See more keywords
Photo from wikipedia

Specific computed virtual chromoendoscopy for detection of peritoneal carcinomatosis: an animal study

Sign Up to like & get
recommendations!
Published in 2017 at "Surgical Endoscopy"

DOI: 10.1007/s00464-017-5442-z

Abstract: BackgroundDetection of an incipient Peritoneal Carcinomatosis (PC) is still challenging, and there is a crucial need for technological improvements in order to diagnose and to treat early this condition. The aim of this study was… read more here.

Keywords: day; study; peritoneal carcinomatosis; contrast ... See more keywords
Photo by martindorsch from unsplash

Surgical management for peritoneal carcinomatosis of appendiceal origin with a high-tumor burden

Sign Up to like & get
recommendations!
Published in 2019 at "Surgery Today"

DOI: 10.1007/s00595-019-01856-z

Abstract: Purpose Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS + HIPEC) is the active treatment for peritoneal carcinomatosis of appendiceal origin. However, surgical management is sometimes difficult in patients with a high-tumor burden. Methods A high-tumor burden was… read more here.

Keywords: patients pci; high tumor; peritoneal carcinomatosis; tumor burden ... See more keywords
Photo from wikipedia

The role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis: a systematic review including evidence from Japan

Sign Up to like & get
recommendations!
Published in 2020 at "Surgery Today"

DOI: 10.1007/s00595-020-02180-7

Abstract: The prognosis of peritoneal carcinomatosis is poor. However, the emergence of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS + HIPEC) as a treatment option has prolonged survival and it can even potentially cure patients with peritoneal carcinomatosis.… read more here.

Keywords: hyperthermic intraperitoneal; surgery hyperthermic; carcinomatosis; treatment ... See more keywords
Photo by nci from unsplash

Prognostic Impact and Utility of Immunoprofiling in the Selection of Patients with Colorectal Peritoneal Carcinomatosis for Cytoreductive Surgery (CRS) and Heated Intraperitoneal Chemotherapy (HIPEC)

Sign Up to like & get
recommendations!
Published in 2020 at "Journal of Gastrointestinal Surgery"

DOI: 10.1007/s11605-020-04886-y

Abstract: Background Recent studies have shown an association in non-metastatic colorectal cancer between patient survival and immunoprofiling (expression of CD3, CD4, CD8, CD45, and FOXP3 T cells at the invasive margin (IM) and the tumor center… read more here.

Keywords: carcinomatosis; crs; cytoreductive surgery; peritoneal carcinomatosis ... See more keywords
Photo from wikipedia

Programmed 'triple-mode' anti-tumor therapy: Improving peritoneal retention, tumor penetration and activatable drug release properties for effective inhibition of peritoneal carcinomatosis.

Sign Up to like & get
recommendations!
Published in 2018 at "Biomaterials"

DOI: 10.1016/j.biomaterials.2018.03.051

Abstract: Peritoneal carcinomatosis (PC) is a fatal condition arising in the gastrointestinal tract. PC patients administered drugs locally in the tumor region, such as in intraperitoneal chemotherapy (IPCh), suffer from low drug retention time and tumor… read more here.

Keywords: tumor penetration; drug; retention; peritoneal carcinomatosis ... See more keywords
Photo from archive.org

The emerging roles of functional imaging in ovarian cancer with peritoneal carcinomatosis.

Sign Up to like & get
recommendations!
Published in 2018 at "Clinical radiology"

DOI: 10.1016/j.crad.2018.03.009

Abstract: This article reviews the emerging roles of functional imaging in the assessment of peritoneal carcinomatosis in ovarian cancer, focusing on the use of diffusion-weighted magnetic resonance imaging (DW-MRI) and 2-[18F]-fluoro-2-deoxy-d-glucose positron-emission tomography combined with computed… read more here.

Keywords: functional imaging; roles functional; emerging roles; ovarian cancer ... See more keywords